Safety and Pharmacokinetics Study of Multiple Dose Administration of Sifuvirtide in HIV-infected volunteers (FS0103).
Phase of Trial: Phase II
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Sifuvirtide (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 21 May 2012 Additional company (Beijing Kaokerui Pharma) added in association as reported by Chinese Clinical Trial Register.
- 21 May 2012 Actual end date changed from Sep 2006 to 31 Jul 2007 as reported by Chinese Clinical Trial Register.
- 21 May 2012 Planned number of patients changed from 52 to 24 as reported by Chinese Clinical Trial Register record.